An observational study in Neuromuscular Blockade, sponsored by Oscar Diaz-Cambronero. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-22.
Sponsored by Oscar Diaz-Cambronero · Observational
The NMB (Neuromuscular Blockade) is the most frequent complication in anesthesiology associated with an increase in adverse respiratory events in the postoperative period. Its appearance depends on multiple factors. The introduction of a comprehensive educational strategy aimed at promoting the proper management of NMB in the intraoperative period and a package of measures that must be performed (intraoperative neuromuscular monitoring and reversal of the effect of neuromuscular blockers) may contribute to a decrease in the incidence of NMB, Increase safety in the surgical patient and decrease associated costs.
Multicenter, epidemiological, prospective, randomized, sequential study. The introduction of an educational program and a package of clinical measures (specific monitoring and pharmacological reversion) in the incidence of NMB will be evaluated by evaluating variations in this incidence of NMB, the rate of compliance with the preventive measures and the perception of the Safety in the perioperative, through pre and postoperative survey.
99 studies on the registry are indexed under Delayed Emergence from Anesthesia; 15 are open to participants now.
This study's enrollment of 2,314 is above the median of 120 across 39 observational studies indexed under Delayed Emergence from Anesthesia.
Browse Delayed Emergence from Anesthesia studies →Oscar Diaz-Cambronero is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients submitted to general anesthesia with neuromuscular blockade, extubated before admission to the Post Anesthesia Recovery Unit
Exclusion Criteria:
Intraoperative neuromuscular monitoring and pharmacological reversion according to data sheet
Behavioral: Educational program for clinicians: implementation of a package of clinical prevention measures of NMB
Treated according to usual clinical practice
Intraoperative neuromuscular monitoring and pharmacological reversion of NMB according to data sheet
Incidence of PORC.
To reduce the incidence of PORC ≤ 10% by the introduction of an educational program and a bundle of preventive measures (including intraoperative monitoring and reversal of neuromuscular blocking agents (NMBA)).
Time frame: Six months, first three months to evaluate PORC incidence and then three months to evaluate PORC incidence after educational intervention.
Compliance rate with the bundle of measures
To evaluate if the educational program increases compliance of clinical preventive measures, if the reduction of incidence of BNMR is maintained, and, in addition, if this compliance is maintained over time.
Time frame: Six months, first three months to evaluate PORC incidence and then three months to evaluate PORC incidence after educational intervention.
Rate of intraoperative monitoring
Rate of compliance of clinical prevention measures with intraoperative monitoring.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
Rate of reversal of NMBA
Rate of compliance of clinical prevention measures with NMBA reversal after surgery.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
Perception of safety -increase- by anesthesiologists
To evaluate, from the point of view of patient safety, whether the perception of safety by clinicians is maintained, through a survey before and after the intervention.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
Incidence of postoperative adverse events.
Incidence of postoperative complications in relation to the NMB reversal rate.
Time frame: Six months, from the beginning, with no intervention, until the end of phase III (end of recruitment in both groups).
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Delayed Emergence from Anesthesia→
Oscar Diaz-Cambronero